|
|
|
|
| LEADER |
00989pam a2200229 a 4500 |
| 001 |
2503766 |
| 003 |
GR-PaULI |
| 005 |
20211026133118.0 |
| 008 |
920409s1994 gw a b 101 0 eng c |
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_329000000000000_CIP
|7 0
|9 329810
|a LISP
|b LISP
|c BSC
|d 2021-10-26
|i 132096
|l 0
|o 615.329 CIP
|p 025000286287
|r 2021-10-26 00:00:00
|t 1
|w 2021-10-26
|y BK15
|
| 999 |
|
|
|c 184595
|d 184595
|
| 020 |
|
|
|a 354058174X
|
| 040 |
|
|
|a DNLM/DLC
|c GR-PaULI
|d
|b gre
|e AACR2
|
| 082 |
0 |
4 |
|a 615.329
|2 23
|
| 245 |
0 |
0 |
|a Ciprofloxacin i. v. :
|b defining its role in serious infection : International symposium, Salzburg, september 1993 /
|c edited by C. Garrard.
|
| 260 |
|
|
|a Berlin :
|b Springer,
|c c1994.
|
| 300 |
|
|
|a 146 σ. :
|b εικ. ;
|c 24 εκ.
|
| 504 |
|
|
|a Περιλαμβάνει βιβλιογραφικές παραπομπές.
|
| 650 |
|
4 |
|a Αντιβιοτικά
|9 29871
|
| 700 |
1 |
|
|a Garrard, C.
|9 188245
|e επιμελητής.
|q (Christopher)
|
| 942 |
|
|
|2 ddc
|c BK15
|
| 998 |
|
|
|c ΜΠΟΥΡΑΣ
|d 2021-10
|
